| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.089 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.058 | 0.6 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |